Mkts

iRadimed Corporation

NASDAQ: IRMD
$85.54-3.04 (-3.43%)
As of Nov 5, 4:00 PM ET

Key statistics

Day range
83.7389.45
52-week range
76.35107.90
Today
Open89.26
Previous close85.54
Volume—
Valuation
Market cap1.13B
P/E ratio49.13×
EPS (TTM)1.79
Income & risk
Dividend / yield—
Beta0.97
Avg volume125.9K
Discussion

IRMD News

Stories mentioning IRMD from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue21,97922,69221,20220,40919,51119,38918,32617,929
Cost of Goods Sold5,1655,6604,7084,4544,6684,6294,1343,919
Gross Profit16,81417,03216,49415,95514,84314,76014,19214,010
Operating Expenses
Research & Development956.00800.00674.00877.00624.00571.00639.00801.00
Sales General & Admin
Total Operating Expenses9,5779,9389,6619,1679,4118,9608,4038,383
Operating Income (Loss)7,2377,0936,8346,7885,4325,8015,7895,627
Interest Income
Interest Expense
Other Expense
Pretax Income7,7697,7917,2987,3275,9456,3446,4186,269
Tax Provision1,9511,3491,7211,5531,2581,1971,3691,368
Net Income (Loss)5,8186,4425,5775,7744,6875,1475,0494,901
Earnings Per Share (Basic)0.460.510.440.450.370.410.400.39
Earnings Per Share (Diluted)0.450.500.430.450.370.400.400.38
Weighted Average Shares Outstanding (Basic)12,78312,72212,72112,71612,71412,67012,67012,665
Weighted Average Shares Outstanding (Diluted)12,87012,85412,86012,83512,82612,78412,77812,758

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About IRMD

iRadimed Corporation (NASDAQ: IRMD) is a stock listed on the Nasdaq Stock Market under the ticker symbol IRMD. It last traded at $85.54 (Nov 5, 2026, 4:00 PM ET), down 3.4% on the day. That gives iRadimed a market capitalisation of $1.1B and a price-to-earnings ratio of 49.1.

Over the past 52 weeks IRMD has traded between $76.35 and $107.90.

Revenue for the quarter ended Mar 31, 2026 was $22.0M; net income $5.8M. Revenue was up 12.6% from $19.5M in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$22.0M$5.8M26.5%
Dec 31, 2025$22.7M$6.4M28.4%
Sep 30, 2025$21.2M$5.6M26.3%
Jun 30, 2025$20.4M$5.8M28.3%

From iRadimed’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…